We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities by Envestors

Metal matrix composite components and materials, primarily comprised of aluminium for use in the engineering and manufacturing industries. Alvant specialise in designing, developing and producing the composite for well-known clients such as Ford and Safran. In the last financial year, Alvant achieved a turnover of almost £617k and has invested more than £10m towards manufacturing and testing their own product. Alvant is now raising funds to distribute their components to a wider market and expand the number of commercial applications that would benefit from their materials.
investment: £1,234,836 target: £2,500,000
status: Active 4 days
to go
More Information
Cambridge Medical Technologies Limited Medical EIS
Cambridge Medical Technologies Limited (CMT) is a medical technology company which operates in the UK and the US. The company specialises in portable and wearable biosensors for medical applications. CMT’s products and subsystems provide clinical accuracy and real-time monitoring of certain blood biomarkers without the need for invasive blood tests. With its range of tech-enhanced medical products, CMT is thriving in the blood testing market, which is expected to reach $62.9bn by 2024.
investment: £1,700,000 target: £5,000,000
status: Active 5 days
to go
More Information
Linear Diagnostics Medical EIS
Linear Diagnostics Limited (LDL) utilises a novel platform technology for assays in a wide range of sectors. With focus on simplicity, speed and sensitivity, LDL uses Linear Dichroism technology to develop a molecular diagnostic platform with the ability to detect multiple targets such as Chlamydia and Gonorrhoea, from a single sample in just 15 minutes. The platform is designed to offer diagnosis and treatment within a single clinical appointment. With the proceeds, this company will build a follow-on pipeline of POC products and explore the potential markers for head trauma.
investment: £61,000 target: £1,000,000
status: Active 33 days
to go
More Information
Zapp Scooters Limited Vehicles and Transport EIS
Zapp Scooters produces zero-emission battery electric vehicles (BEV) by utilising green processes, renewal energy sources and recyclable components as part of the company’s gen-2 environmental promise. Its first product was the i300, a 300cc ICE class equivalent scooter that incorporates many unique ‘modern’ style designs and technical features, previously available only on superbikes. Leveraging on its strong supply chain and government support, Zapp Scooters will assemble the scooters in Thailand. Following the company’s recent official UK/EU launch, the i300 received notable attention in the automotive and technology press. Moreover, consumers and dealers have already ordered more than 700 units of the i300.
investment: £706,125 target: £2,000,000
status: Active 5 days
to go
More Information
vzInternet Limited Technology EIS
A cyber-defence system preventing criminals accessing secure information from internet-enabled businesses. vzInternet Limited have developed Assayer, a cloaking tool that works differently to traditional cybersecurity systems. Assayer aims to tackle criminal behaviour by removing the time they have to exploit an organisation, rather than current methods that only add more layers for criminals to break through. vzInternet Limited is in the process of creating three version of their Assayer range, targeted for specific needs. Assayer Freedom is the initial offering that will prevent criminals from using stolen information and biometric data to access private material. Assayer Trust aims to tackle malware designed to convince customers to provide personal information and Assayer Veto is being created to protect businesses from internal attacks by employees and third-party contractors.
investment: £60,000 target: £500,000
status: Funded 34 days
to go
More Information
Living With Medical EIS
A medical condition management platform allowing clinicians to create their own app to improve a patient's health whilst reducing costs. Living With develops smart apps specific to a person's condition, they currently have 3 products with another in the development stage. Their primary app, Squeezy, is the top paid medical app in the UK that helps patients with their pelvic floor exercises. Other apps, allow clinicians to monitor a patient's bowel and bladder health, as well as those with rheumatoid arthritis. These apps are already in use at multiple NHS Trusts and clinics. Funds are being raised to complete development of their apps to help those with lupus and lung cancer, in addition to further developing their existing products. The company aims to have thousands of apps that will be available worldwide to provide self-service treatment at any time. Living With is expecting to earn £1.07m in revenue by the end of March 2019.
investment: £103,000 target: £350,000
Libertine FPE Technology EIS
Libertine is a maker of smart engines for electric vehicles and distributed power generation. The company designs and licenses high-performance linear motor-generator systems and supplies them in the form of a technology platform that enables customers to build Smart Engine generator products. It's Linear Power System technologies can be used in a broad range of power generation, cooling, heating, and transport applications. Further, Libertine’s technology helps make decentralised power generation the norm, bringing reliable, clean, and affordable power wherever it is needed. This company's smart engines are estimated to play a significant role in power generation and global transport for decades to come.
investment: £700,000 target: £700,000
status: Extended 7 days
to go
More Information
Food Hall Group Limited Film, Entertainment & Media EIS
Food Hall Group is an artistic production house and agency that specialises in creating high-quality and creative digital content for major UK and international food and beverage brands. The Food Hall team has created numerous national and global food and drink campaigns. It has also collaborated with brands such as Martini, McDonald's, Lipton, Bacardi, Heinz, KFC, Nando's, Sainsbury's, Iceland and many more. In the first year of trading, Food Hall had generated a revenue of £340k that resulted in a positive EBITDA (c.£25k). Food Hall is now seeking a £300k increase in revenue. It is planning to extend its provision of marketing solutions direct-to-client, including branded content, brand strategising, media buying and amplification.
investment: £0 target: £300,000
status: Funded 53 days
to go
More Information
Billon have created a technology that enables zero cost global payments by the use of a simple mobile app. Billon's mobile app allows you to instantly pay for the rest of an article from the Guardian or even donate to your favourite Youtubers with a few clicks of a button. 
investment: £1,406,667 target: £900,000
Brands Reunited Ltd Catering, Food and Drink EIS
Brands reunited are looking to disrupt the modern craft beer market. Their sales are over £400k and are growing 100% year on year. They have two brands that are already in Watneys and Home Ales. The funding will be spent on building their brand and the team. 
investment: £255,000 target: £500,000
Sano Holdings Limited Catering, Food and Drink EIS
The mission at sano is to bring education and knowledge to everybody, so that they can eat healthly and take control of their own health. The strategy behind Sano to go is to become a leader in the healthy food delivery market.
investment: £0 target: £600,000
Sense Products is a food supplement company that currently have 5 products on the market; Sense for a night out (alcohol), Sense for nicotine lovers (smokers), Sense for cholesterol, Sense for city living (busy lives) and Sense for weight warriors.
investment: £200,000 target: £350,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph